Physicians must be vigilant of the impact that various medications can have on sexual function, including those less commonly associated with sexual side effects, to ensure holistic patient care and adherence to treatment.

Stay abreast of the latest HCPCS updates crucial for oncology practice, including new codes for advanced cancer treatments and essential guidelines for principal illness navigation services, to ensure compliance and optimize reimbursement.

Explore the latest insights into the complex pathophysiology of steroid-refractory cGVHD and the significant strides made in treatment options, including the impactful roles of ruxolitinib, belumosudil, and ibrutinib in enhancing patient outcomes.

Embrace the future of healthcare with AI-driven value-based care models, designed to optimize patient outcomes while addressing the pressing challenge of rising healthcare costs.

Under Dr. Laurie Glimcher’s leadership, Dana-Farber Cancer Institute is embarking on a transformative journey with the creation of a new, dedicated cancer hospital, promising a future of specialized care and improved patient experiences in oncology.

This historical analysis reveals the medical community’s involvement in advocating eugenic practices, emphasizing the need for modern physicians to understand and confront the lasting impact of these ideologies on healthcare and society.